BRENT PLUMMER: Open Payments
NPI 1083107056 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 57 payments from 10 companies in 2025. Trend: 2023 $2,483 · 2024 $2,198 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $420 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $401 |
| Teva Pharmaceuticals USA, Inc. | 11 | $378 |
| Axsome Therapeutics, Inc. | 8 | $350 |
| Luye Pharma (USA) Ltd. | 5 | $205 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Noven Therapeutics, LLC | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, Auvelity, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, UZEDY, Secuado.
Industry payments across KY — which companies pay providers there.
